Cytoreductive surgery in the management of malignant ascites from Adenocarcinoma of Unknown Primary (ACUP)

Current Surgery

Volumn 62, Issue 5, 2005, Pages 500-503

  Spurgeon, Jade M ^a   Cotlar, Alvin M ^a  

^a KEESLER MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma of unknown primary (ACUP); Chemotherapy; Cytoreduction; Palliative surgery

Indexed keywords

CARBOPLATIN; DOCETAXEL; ETOPOSIDE; PACLITAXEL;

ABDOMEN; ADENOCARCINOMA; ADULT; ARTICLE; ASCITES TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIGESTIVE SYSTEM CANCER; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OMENTUM; PELVIS; PERIPHERAL NEUROPATHY; PERITONEUM METASTASIS; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; SIGNET RING CARCINOMA; SURVIVAL TIME;

ADENOCARCINOMA; ASCITES; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, UNKNOWN PRIMARY; OMENTUM; PALLIATIVE CARE; PERITONEAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 23944474270     PISSN: 01497944     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cursur.2005.03.001     Document Type: Article

References (14)

1. Rubin SC, Sutton GP, ed. Ovarian Cancer. New York: McGraw-Hill; 1993:361-364
2. Abeloff MD, Armitage JO, Lichter AS, Nederhuber JE, eds. Abeloff: Clinical Oncology. 3rd ed. New York: Churchill Livingstone; 2004:2627
3. Chorost MI, Mckinley B, Tschoi M, Chosh BC. The management of the unknown primary. J Am Coll Surg. 2001;193:666-677
4. Abeloff MD, Armitage JO, Lichter AS, Nederhuber JE, eds. Abeloff: Clinical Oncology. 3rd ed. New York: Churchill Livingstone; 2004:2623
5. Newman KH, Nystrom JS. Metastic cancer of unknown origin: Non-squamous cell type. Semin Oncol. 1982;9:427
6. Fauci AS, Braunwald E, Isselbacher KJ, ed. Harrison's Principles of Internal Medicine. 14th ed. New York: McGraw-Hill; 1998:614-618
7. Lembersky BC, Thomas LC. Metastases of unknown primary site. Med Clin North Am. 1996;80:153-171
8. Sebbag G, Shmookler BM, Chang D, Sugarbaker PH. Peritoneal carcinomatosis from an unknown primary site. Management of 15 patients. Tumori. 2001;87:67-73
9. Chi DS, Welshinger M, Venkatraman ES, Barakat RR. The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol Oncol. 1997;67:56
10. Sugarbaker PH. Peritonectomy procedures. Surg Oncol. 2003;12:703-727
11. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727-731
12. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790-796
13. Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol. 2003;21: 799-806
14. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trialof cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-3743